[go: up one dir, main page]

CR10685A - Proceso para estabilizaciuon de famotidina - Google Patents

Proceso para estabilizaciuon de famotidina

Info

Publication number
CR10685A
CR10685A CR10685A CR10685A CR10685A CR 10685 A CR10685 A CR 10685A CR 10685 A CR10685 A CR 10685A CR 10685 A CR10685 A CR 10685A CR 10685 A CR10685 A CR 10685A
Authority
CR
Costa Rica
Prior art keywords
famotidine
stabilization process
stabilization
famotidine stabilization
Prior art date
Application number
CR10685A
Other languages
English (en)
Inventor
Armenta Maria Elena Garcia
Ochoa Victor Guillermo Alvarez
Murillo Josefina Santos
Original Assignee
World Trade Imp Export Wtie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Trade Imp Export Wtie Ag filed Critical World Trade Imp Export Wtie Ag
Publication of CR10685A publication Critical patent/CR10685A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CR10685A 2006-09-25 2009-03-24 Proceso para estabilizaciuon de famotidina CR10685A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA06010972A MXPA06010972A (es) 2006-09-25 2006-09-25 Proceso para estabilizacion de famotidina.

Publications (1)

Publication Number Publication Date
CR10685A true CR10685A (es) 2009-05-22

Family

ID=39230698

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10685A CR10685A (es) 2006-09-25 2009-03-24 Proceso para estabilizaciuon de famotidina

Country Status (8)

Country Link
EP (1) EP2085079A2 (es)
AR (1) AR062987A1 (es)
BR (1) BRPI0717425A2 (es)
CL (1) CL2007002760A1 (es)
CO (1) CO6160290A2 (es)
CR (1) CR10685A (es)
MX (1) MXPA06010972A (es)
WO (1) WO2008039052A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX351059B (es) * 2012-08-17 2017-09-29 Laboratorios Senosiain S A De C V Star Composicion farmaceutica oral en forma de microesferas y proceso de elaboracion.
MA46713A (fr) * 2016-11-01 2019-09-11 Johnson & Johnson Consumer Inc Forme posologique pharmaceutique orale liquide comprenant un antagoniste du récepteur h2 à l'histamine et un antiacide
EP3687502B1 (en) * 2017-09-29 2023-06-07 Johnson & Johnson Consumer Inc. Solid simethicone particles and dosage form thereof
US11433024B2 (en) 2018-04-27 2022-09-06 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form
EA202191063A1 (ru) 2018-10-18 2021-07-12 Джонсон энд Джонсон Консьюмер Инк. Новая дозированная форма
CA3156028A1 (en) * 2019-09-27 2021-04-01 Johnson & Johnson Consumer Inc. Gel-chewable dosage form

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ503823A (en) * 1997-10-27 2002-04-26 Sumitomo Pharma Amide derivatives and their use in treating retinal neurodegenerative disorders
US20050053655A1 (en) * 2003-09-05 2005-03-10 Pharmaceutical Industry Technology And Development Center Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same

Also Published As

Publication number Publication date
EP2085079A2 (en) 2009-08-05
WO2008039052A8 (es) 2009-05-07
AR062987A1 (es) 2008-12-17
BRPI0717425A2 (pt) 2013-11-12
WO2008039052A3 (es) 2008-06-19
CL2007002760A1 (es) 2008-04-25
CO6160290A2 (es) 2010-05-20
MXPA06010972A (es) 2009-04-17
WO2008039052A2 (es) 2008-04-03

Similar Documents

Publication Publication Date Title
MX304143B (es) Composición estabilizante para polímeros
BRPI0716528A2 (pt) mÉtodo de estabilizaÇço
BRPI0818546A2 (pt) Misturas de enzimas para fermentação
EP2087096A4 (en) MODIFIED CYANOBACTERIA
DK3354267T3 (da) Stabiliseret sulforaphan
DE602007012130D1 (de) Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase
DOS2008000026S (es) Confiteria
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
EP1985418A4 (en) SHAVER
BRPI0813670A2 (pt) Compostos para tratamento
EP2183425A4 (en) STABILIZED DEHYDRATION COMPOSITION
BRPI0923401A2 (pt) Métodos para o preparo de aril amidas.
DE502007004064D1 (de) Querträger
SE0801651L (sv) Granuleringskvarn
FI20060795A0 (fi) Kylläisyyttä aiheuttava tuote
LU93092I2 (de) Alemtuzumab
CR10685A (es) Proceso para estabilizaciuon de famotidina
EP2054074A4 (en) MODIFIED ERYTHROPOIETIN
BRPI0816288A2 (pt) Processos e compostos
PT2062053E (pt) Métodos de imunoensaio melhorados
BRPI0812105A2 (pt) Neramexano para o tratamento de nistagmo
DK2089708T3 (da) Forudsigelige kræft-immunterapi parametre
EP1973351A4 (en) MONITOR
ES1065835Y (es) Caperuza para cetreria
DE112007003228A5 (de) Temperiervorrichtung

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)